SCHEMBL15623135

SCHEMBL15623135

CCCCCc1ccc(S(=O)(=O)NC(CC)(CCCC)CC(=O)O)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 9/20 0.49
▸ GAB1 Q13480 2/20 0.49
▸ IRS1 P35568 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.46
▸ HAO1 Q9UJM8 1/20 0.45
▸ CA2 P00918 2/20 0.45
▸ LMNA P02545 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ TRPV1 Q8NER1 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ PDPK1 O15530 1/20 0.44
▸ ABCB11 O95342 1/20 0.44
▸ AKT2 P31751 1/20 0.44
▸ AKT3 Q9Y243 1/20 0.44
▸ GHSR Q92847 2/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA9 Q16790 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15623136 0.95 AKT1 (0.49) AKT1GAB1IRS1ALDH1A1HAO1
SCHEMBL15623170 0.94 AKT1 (0.52) AKT1GAB1IRS1ALDH1A1HAO1
SCHEMBL15623137 0.75 HAO1 (0.49) ALDH1A1HAO1TRPV1
SCHEMBL15623138 0.73 S1PR1 (0.60) CA2GHSRCA12CA1CA9
SCHEMBL4476875 0.72 LMNA (0.64) AKT1GAB1IRS1ALDH1A1LMNA
SCHEMBL15881011 0.71 ALDH1A1 (0.51) ALDH1A1HAO1
SCHEMBL7151939 0.70 FFAR1 (0.78) AKT1GAB1CA2KDM4EPDPK1
SCHEMBL26965400 0.70 CA2 (0.64) AKT1GAB1ALDH1A1CA2LMNA
SCHEMBL14822992 0.69 NPSR1 (0.51) AKT1GAB1IRS1ALDH1A1HAO1
SCHEMBL28546119 0.69 CA2 (0.58) AKT1GAB1IRS1ALDH1A1HAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680282-B2 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer UNIVERSITY HEALTH NETWORK (CA) 2014-03-25 — — US disclosed
Send feedback